SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is seeing intense volatility and social media discussion following a strategic partnership with NVIDIA that includes a multi-billion dollar warrant deal, which investors are weighing against a significant earnings miss. The community is heavily divided, with bulls pointing to the company's long-term pivot toward AI infrastructure and hyperscaler demand, while bears are expressing skepticism over the timing of the news release and the company's path to profitability.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending as investors weigh a record-shattering revenue backlog of nearly $100 billion against concerns over aggressive capital expenditure and debt-fueled growth. While the community remains deeply divided between long-term bulls betting on dominant AI infrastructure demand and skeptical bears pointing to recent margin compression, the stock's volatility is being exacerbated by heavy institutional hedging and uncertainty surrounding post-earnings price swings.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is facing extreme investor anxiety and bearish sentiment heading into its earnings release, with shareholders pointing to a consistent pattern of post-earnings sell-offs and a lack of executive transparency. While some investors are betting on a short squeeze or a potential OpenAI partnership, many are actively calling for leadership changes following significant executive turnover and a prolonged period of share price underperformance.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as the community debates a strategic legal maneuver to rescind their U.S. distribution agreement with NS Pharma, a move seen by many as a calculated effort to clear the path for a potential buyout or a more effective commercial rollout. Investors are actively discussing the implications of this contract dispute on the timeline for Deramiocel ahead of its upcoming PDUFA date, with optimism centered on the possibility of a stronger, independent launch or a new partnership.

Cloudflare, Inc. engages in the provision of cloud-based services to secure websites. It offers various products for performance and reliability, video streaming and delivery, advanced security, insights, Cloudflare for developers, domain registration, and Cloudflare marketplace. It operates through the United States and Rest of the World geographical segments. The company was founded by Matthew Prince, Michelle Zatlyn, and Lee Holloway in July 2009 and is headquartered in San Francisco, CA.

Cloudflare Inc - Ordinary Shares - Class A

Cloudflare Inc

Cloudflare is experiencing significant volatility following a 20% workforce reduction and a strategic shift toward an agentic AI-first operating model. While investors are debating whether the company's AI-driven efficiency gains and exponential platform usage justify its premium valuation, the community remains sharply divided between those viewing the pullback as a buying opportunity and those concerned about the company's long-term profitability.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is experiencing a significant surge in trading volume and investor interest following a strong quarterly earnings report that highlighted substantial revenue growth and new large-scale AI engagements. The community is actively discussing a potential short squeeze driven by heavy short interest, while investors debate the company's long-term valuation and potential for further expansion within the AI data infrastructure sector.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as investors react to strategic momentum in its QNX automotive software, driven by new partnerships and growing integration in industrial robotics and edge AI infrastructure. The community is actively discussing a perceived valuation gap, with many holders pointing to these structural wins as catalysts for long-term growth as the company moves further away from its legacy consumer hardware identity.

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.

Atara Biotherapeutics Inc

Atara Biotherapeutics is facing significant market volatility following a second FDA rejection for its tabelecleucel therapy, with community debate centered on whether this reversal constitutes an unfair clinical trial assessment or an irreparable blow to the company's limited cash runway. Traders are actively discussing the risks of potential dilution and the company's future viability, while many remain focused on the potential for an expedited meeting to challenge the FDA's decision.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is gaining attention following the release of its first-quarter 2026 financial results and an update on the pivotal Phase 3 registration path for CAD-1005 in patients with Heparin-Induced Thrombocytopenia. While some investors view the FDA-aligned regulatory progress as a key de-risking milestone, others in the community have expressed skepticism, citing frequent bot-driven spam and concerns over the company's long-term capital requirements.

Datadog, Inc. engages in the development of a monitoring and analytics platform for developers, information technology operations teams and business users. Its platform integrates and automates infrastructure monitoring, application performance monitoring and log management to provide real-time observability of its customers' entire technology stack. The company was founded by Olivier Pomel and Alexis Lê-Quôc on June 4, 2010 and is headquartered in New York, NY.

Datadog Inc - Ordinary Shares - Class A

Datadog Inc

Datadog is seeing a significant rebound as market sentiment shifts from fearing AI-driven SaaS disruption to valuing the company as essential infrastructure for managing complex, AI-heavy cloud environments. Investors are actively debating the sustainability of this rally, with many focusing on accelerating enterprise demand, expanding margins, and the critical role the platform plays in observability as AI adoption grows.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


ELGX
Endologix Inc.

Feed

News

Sentiment

Fundamentals

Info

Compact View

Poll

Latest ELGX News

ELGXEndologix Inc.